FDA Clarifies Scope of Major Deficiencies in ANDAs

By January 17, 2017 Generic Line No Comments

The FDA has again updated guidance on its criteria for refusing to receive an ANDA, providing a broader definition for major deficiencies and downgrading four major deficiencies to minor ones in order to make requirements less burdensome for industry.
Source: Generic Line